Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
about
Senescence of activated stellate cells limits liver fibrosisOvercoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis.Genomic analysis of CD8+ NK/T cell line, 'SRIK-NKL', with array-based CGH (aCGH), SKY/FISH and molecular mapping.EGFR activation suppresses respiratory virus-induced IRF1-dependent CXCL10 productionCD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cellsThe interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitopeExtranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsUse of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in Type 1 diabetesAnti-CD138-targeted interferon is a potent therapeutic against multiple myeloma.Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules.The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma.STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma.Natural killer cell lines in tumor immunotherapy.HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.Statins inhibit proliferation and cytotoxicity of a human leukemic natural killer cell line.JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells.Molecular analysis of tumor suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in natural killer cell neoplasms.NKL homeobox gene MSX1 acts like a tumor suppressor in NK-cell leukemia.Terminal differentiation in vitro of patient-derived post-TMD megakaryoblastic AML cells.Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.Single Degranulations in NK Cells Can Mediate Target Cell Killing.Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms.Combination statin and chemotherapy inhibits proliferation and cytotoxicity of an aggressive natural killer cell leukemia
P2860
Q17149636-54B714F6-EDCE-46AB-ABD2-EE4606922D2AQ54872411-64114959-89D7-47A2-A4CA-C64ED56884A6Q54899912-709315B5-2E34-46E9-AD0A-5FC3F1FB31EDQ54930662-8E8AD38A-7BDE-4A9F-BBF5-D7294D90A462Q54930680-9E9591B9-DBD4-4E15-AD40-0BABC017BE24Q54972595-56A9F808-4DA3-426C-98EA-1712CF5AA803Q54995532-177737BF-EA5D-4D81-BEB4-6AF72820E5B0
P1343
Q24621822-4955FEB9-9B04-4E9B-8D48-FD08B5496316Q30544833-3F529AC5-014C-4320-BCAC-33BCD692180FQ33793137-08786ACC-A348-457F-A557-75C363EDD51EQ33913781-BB8BDBF2-A579-45A9-BC01-4EC09AB2B79DQ34772159-CB0F4F30-FC40-4FD3-A048-DAD2943A69A4Q34810328-A35AEAEA-98B6-445C-A248-3E72247A8597Q34898306-9F4229B2-CABA-4AF9-B9D2-7ECF33038B02Q35062538-3DB9505F-195F-4C84-85F4-5F3CE5912BDBQ35321868-CCABFAF0-4E5F-4110-AB09-A39F213BFFC1Q35947316-F8F658A9-DE97-4067-93BF-EDF43493B8DAQ36431461-05DBFCD6-89DA-45B9-81DF-EC4CFC2A2937Q36684556-FF5686CD-343C-468D-AAB1-C9E973716FBDQ37485330-4F049EA3-C20A-41AE-BB35-42455D5AD3C2Q37998371-DC37D178-1960-484D-963D-BD811CC188CBQ38835585-3D59E2A0-F447-4FD8-882E-5CB7588B36F3Q39041431-D522FDB1-6079-4168-99D0-AF675B1DE3ADQ39149556-30586496-CEA7-4487-BE1F-A09D114B955CQ39525496-F394FD9D-DBE3-404F-B8E9-C80CBB4645FFQ39647341-7C22672B-58B7-435D-9BCF-384432CD35E4Q40048369-D99A75FC-00CC-4A3F-AE86-DE075F5D5E42Q40772738-A229911C-C678-47BC-9716-476E02B1689AQ42366512-69C33DC4-4FBD-4A68-BF59-3FD202219E32Q44544284-929D9FFF-C945-4BA6-AA46-DDCBB5D90BDAQ50022186-EA1BFE53-9E2C-4520-9652-EA15896293ACQ54246661-C73D6A00-5299-45AC-B565-4F2C4EF242B8Q55100479-9A62F7E8-7A05-4092-B3CF-607CF3D7317CQ58793391-934C2D50-2577-4843-AA7B-0E18F30B0B5A
P2860
Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@ast
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@en
type
label
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@ast
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@en
prefLabel
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@ast
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@en
P4510
P356
P1433
P1476
Malignant hematopoietic cell l ...... killer cell leukemia-lymphoma.
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2401778
P577
2000-05-01T00:00:00Z
P5875
P6179
1016129065